Danish cattle crisis reveals flaws in fast-tracked Bovaer climate drug approval

By Don Want PhD

Hundreds of farms report health issues after the methane-reducing feed additive mandate exposes regulatory failures.

Bovaer has been introduced into the Australian cattle herd with reported mixed results ranging from no adverse reactions to cattle wasting.

Labor and Greens naively back its use because they believe it will stop global warming, but it is not yet a mandated feed additive.

Meat consumers have been avoiding its potential contamination yet Australia’s largest meat packer, Brazilian conglomerate JBS has told Cairns News the company does not use Bovaer in its large network of feedlots, contrary to what some independent butchers have told us.

The dairy industry says it is not yet being fed to dairy cattle thus contaminating milk.

When Denmark mandated a methane-reducing feed additive for dairy cattle in January 2025, the government promised a major climate breakthrough. By October, more than 350 farms were reporting cattle deaths, declines in milk production, and reproductive failures. The crisis has revealed serious flaws in the regulatory approval process for Bovaer®—a pharmaceutical compound now used in more than 70 countries, including Australia, where it was approved without sufficient safety testing.

Wildly Inconsistent Results

Bovaer® (3-nitrooxypropanol) works by inhibiting a specific enzyme in the digestive systems of cows to reduce methane emissions. However, research shows that its effectiveness varies greatly depending on the diet, ranging from a 7% reduction in grass-fed cattle to 40-50% in grain-fed operations. Despite this 500-700% variation, regulators approved a standard dose for all production systems.

“I know personally dozens of farmers who have had serious problems with their cows after introducing Bovaer,” Danish farmer Andreas Ring told investigators. Within two days of stopping Bovaer®, his herd’s health markers improved by 20%. The pattern was clear: issues were concentrated in pasture-based farms feeding high-fibre diets—precisely where research showed minimal efficacy.

Critical Safety Gaps

Animal studies showed that Bovaer® metabolites accumulated in bone marrow, with concentrations doubling with repeated dosing. Yet regulatory assessments lasted only five days, despite cattle potentially receiving daily doses for years.

More concerning, researchers couldn’t identify all compounds in animal tissues. The European Food Safety Authority acknowledged that in liver tissue, “a mixture of putative metabolites was present, making it impossible to elucidate their structure.” Translation: they don’t know what chemicals are accumulating in organs.

No long-term studies have examined the effects of consuming products from treated cattle. Regulators claimed the compound is “fully metabolised,” but this depends on detection limits rather than a confirmed absence. Trace amounts below the 5 microgram per kilogram threshold could be present but undetected.

Attacking Complexity with Simplicity

The cow’s rumen hosts one of Earth’s most complex microbial ecosystems. Traditional methods can culture only 10-20% of rumen bacterial species. Modern genomic techniques have identified more than 4,941 previously unknown microbial genomes and 69,000 enzymes, 90% of which are entirely novel. This doesn’t mean that how they all work together, however.

Targeting a single enzyme in this barely-understood system exemplifies “reductionist innovation”—applying narrow fixes to complex biology based on incomplete knowledge. Rumen microbes influence not just digestion but also immune function, metabolism, and gene expression throughout the animal.

Misplaced Priorities

The regulatory push for Bovaer® rests on claims that livestock account for 14.5% of global greenhouse gas emissions. Yet this masks crucial distinctions. Unlike methane from fossil-fuel reservoirs, cattle methane comes from recently grown plants. This biogenic methane oxidises to CO₂ within 10-12 years and gets reabsorbed—a cyclical process fundamentally different from burning ancient carbon.

During the Late Pleistocene, megafauna produced 5-6 times more methane than current livestock. Mesozoic dinosaurs generated an estimated 520 million tonnes of methane annually—comparable to today’s total global methane emissions. These high levels occurred during glacial periods 5-6°C colder than today.

Meanwhile, satellite data identified 1,200 “ultra-emitter” fossil fuel events in 2019-2020, each releasing at least 25 tonnes of methane per hour. A single Algerian oil field plume stretched 200 kilometres and persisted for days. These facilities receive minimal oversight while farmers face pharmaceutical mandates.

Natural Solutions Ignored

Methanotrophic bacteria in healthy grassland soils oxidise 50-90% of biological methane. Modern industrial agriculture has degraded these populations through chemical inputs, soil compaction, and monoculture. Agricultural soils now exhibit methane uptake rates seven times lower than those in native grasslands.

Well-managed regenerative grazing can sequester 3-13 tonnes of soil carbon per hectare annually—potentially offsetting methane emissions. Instead of restoring natural processes, regulators approved a pharmaceutical solution targeting symptoms while ignoring causes.

The Carbon Credit Factor

Bovaer®’s approval occurred amid significant economic incentives. The USDA awarded more than US$90 million in fiscal year 2023 for dairy methane-reduction projects. Distributors project returns of “US$20 or more per cow” through carbon markets—a potential US$188 million annual U.S. market.

Recent scandals raise red flags. Federal prosecutors charged CQC Impact Investors with fraud for obtaining millions of invalid carbon credits. Investigations found 94% of major rainforest offset credits were “phantom credits.” The voluntary carbon market value dropped 61% in 2023 following these revelations.

Only 18 U.S. universities and six USDA research stations can accurately measure livestock methane emissions. Carbon credit protocols don’t account for Bovaer®’s diet-dependent efficacy, risking over-crediting when compounds achieve minimal reductions.

International Response

Norway’s largest milk supplier suspended its Bovaer® rollout following the Danish crisis. The UK’s Arla Foods ended trials early. Denmark’s Veterinary Administration now allows farmers to immediately exempt cattle if they suspect health problems—effectively acknowledging the severity of reported issues.

Veterinarian Tina Bennedsgaard noted affected farms were “mainly pasture-based operations”—confirming concerns about applying feedlot study data to different production systems.

Reform Needed

The Bovaer® approval represents systemic failure. Agencies relied on short-term studies conducted in controlled environments that used grain-rich diets supplemented with undisclosed antibiotics. They approved a universal application despite tenfold variations in efficacy. They accepted incomplete metabolite characterisation and waived pharmaceutical safety requirements by classifying Bovaer® as a feed additive, despite the FDA acknowledging it acts pharmacologically.

Until reforms are implemented, a moratorium on “enforcement discretion” waivers for pharmaceutical compounds is warranted. Products with climate benefits should be subject to stricter oversight, not to reduced requirements. The burden of proof belongs with manufacturers and regulators to demonstrate safety across all conditions—not with farmers to prove harm after widespread adoption.

The Danish crisis demonstrates what happens when economic incentives and approval timelines override thorough assessment of complex biological systems. The precautionary principle demands caution.